UK markets open in 5 hours 46 minutes

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
114.57-0.17 (-0.15%)
At close: 01:00PM EST
114.30 -0.27 (-0.24%)
After hours: 02:56PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
876,047
701,887
540,099
380,833
301,034
Cost of revenue
140,934
97,049
63,382
56,586
34,193
Gross profit
735,113
604,838
476,717
324,247
266,841
Operating expenses
Research development
860,582
771,182
722,343
560,909
401,843
Selling general and administrative
408,998
282,660
317,875
284,812
209,983
Total operating expenses
1,270,294
1,054,548
1,040,880
846,570
612,691
Operating income or loss
-535,181
-449,710
-564,163
-522,323
-345,850
Interest expense
-
63,525
59,947
30,669
33,709
Total other income/expenses net
-112,194
93,933
68,075
-168,126
10,139
Income before tax
-710,546
-418,948
-553,065
-713,880
-362,610
Income tax expense
5,679
-168
1,063
1,195
-692
Income from continuing operations
-716,225
-418,780
-554,128
-715,075
-361,918
Net income
-716,225
-418,780
-554,128
-715,075
-361,918
Net income available to common shareholders
-716,225
-418,780
-554,128
-715,075
-361,918
Basic EPS
-
-5.15
-7.11
-9.71
-5.46
Diluted EPS
-
-5.15
-7.11
-9.71
-5.46
Basic average shares
-
81,262
77,956
73,615
66,250
Diluted average shares
-
81,262
77,956
73,615
66,250
EBITDA
-
-317,406
-466,207
-652,664
-316,656